GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

Last update: 22 Jan, 10:55AM

83.02

1.92 (2.37%)

  • 1D 2.37%
  • 5D 3.36%
  • 1M -3.19%
  • 6M 16.77%
  • YTD 0.24%
  • 1Y -5.27%
  • 5Y 38.37%
Previous Close 81.10
Open 81.43
Volume 1,964,339
Avg. Volume (3M) 3,671,640
Market Cap 37,903,777,792
Price / Earnings (TTM) 17.19
Price / Earnings (Forward) 16.61
Price / Sales 1.78
Price / Book 3.59
52 Weeks Range
57.65 (-30%) — 94.80 (14%)
Earnings Date 4 Feb 2026
TTM Dividend Yield 0.17%
Profit Margin 11.03%
Operating Margin (TTM) 14.78%
Diluted EPS (TTM) 4.76
Quarterly Revenue Growth (YOY) 2.70%
Quarterly Earnings Growth (YOY) 50.80%
Total Debt/Equity (MRQ) 97.51%
Current Ratio (MRQ) 0.980
Operating Cash Flow (TTM) 1.78 B
Levered Free Cash Flow (TTM) 1.58 B
Return on Assets (TTM) 5.87%
Return on Equity (TTM) 26.44%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Bearish Bearish
Health Information Services (Global) Bearish Bearish
Stock GE HealthCare Technologies Inc. Bullish Bearish

AIStockmoo Score

0.1
Analyst Consensus 1.5
Insider Activity NA
Price Volatility 2.0
Technical Moving Averages -2.5
Technical Oscillators -0.5
Average 0.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
GEHC 38 B 0.17% 17.19 3.59
TEM 12 B - - 18.76
HQY 7 B - 38.22 3.43
BTSG 7 B - 69.35 3.87
RCM 6 B - - 2.14
WAY 6 B - 46.57 1.59

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
Sector Healthcare
Industry Health Information Services
Investment Style Mid Core
% Held by Insiders 0.28%
% Held by Institutions 80.26%
52 Weeks Range
57.65 (-30%) — 94.80 (14%)
Price Target Range
77.00 (-7%) — 105.00 (26%)
High 105.00 (Jefferies, 26.48%) Buy
Median 92.00 (10.82%)
Low 77.00 (UBS, -7.25%) Sell
Average 92.00 (10.82%)
Total 6 Buy, 4 Hold, 1 Sell
Avg. Price @ Call 81.03
Firm Date Target Price Call Price @ Call
Barclays 06 Feb 2026 87.00 (4.79%) Hold 78.78
Evercore ISI Group 05 Feb 2026 98.00 (18.04%) Buy 78.78
Morgan Stanley 05 Feb 2026 85.00 (2.38%) Hold 78.78
Stifel 05 Feb 2026 98.00 (18.04%) Buy 78.78
07 Jan 2026 95.00 (14.43%) Buy 85.76
Wells Fargo 05 Feb 2026 97.00 (16.84%) Buy 78.78
BTIG 04 Feb 2026 91.00 (9.61%) Buy 78.78
21 Nov 2025 87.00 (4.79%) Buy 76.45
Piper Sandler 30 Jan 2026 94.00 (13.23%) Buy 78.97
UBS 15 Jan 2026 77.00 (-7.25%) Sell 82.51
B of A Securities 05 Jan 2026 92.00 (10.82%) Hold 85.04
Citigroup 11 Dec 2025 88.00 (6.00%) Hold 86.05
Jefferies 11 Dec 2025 105.00 (26.48%) Buy 86.05
Show more

No data within this time range.

  • 3M
Date Type Details
04 Feb 2026 Announcement GE HealthCare reports fourth quarter and full year 2025 financial results
02 Feb 2026 Announcement GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite
06 Jan 2026 Announcement GE HealthCare Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited
06 Jan 2026 Announcement NXP and GE HealthCare Accelerate AI Innovation in Acute Care
05 Jan 2026 Announcement GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026
29 Dec 2025 Announcement GE HealthCare management to present at upcoming investor conference
16 Dec 2025 Announcement GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners
03 Dec 2025 Announcement GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care
03 Dec 2025 Announcement University of Rochester Medical Center and GE HealthCare form seven-year Care Alliance to build advanced capabilities across system
02 Dec 2025 Announcement GE HealthCare introduces advanced imaging solutions powered by NVIDIA technology to support timely diagnoses and streamlined clinical workflows
01 Dec 2025 Announcement GE HealthCare unveils Allia Moveo, designed to deliver next-level mobility, workflow and comfort in the interventional suite
30 Nov 2025 Announcement GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025
30 Nov 2025 Announcement GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability
26 Nov 2025 Announcement GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality
25 Nov 2025 Announcement GE HealthCare introduces Genesis™ Radiology Workspace: a cloud-first solution with a goal for smarter, faster diagnosis
24 Nov 2025 Announcement GE HealthCare announces cash dividend for fourth quarter of 2025
24 Nov 2025 Announcement GE HealthCare’s Photonova™ Spectra with Deep Silicon reimagines photon-counting CT to see more, know more and achieve more
20 Nov 2025 Announcement GE HealthCare to acquire Intelerad, advancing cloud-enabled enterprise imaging across care settings
17 Nov 2025 Announcement GE HealthCare announces Flyrcado milestone: Strong pilot results drive broader rollout at CVAUSA
16 Nov 2025 Announcement GE HealthCare management to present at upcoming investor conference
12 Nov 2025 Announcement GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning
Show more
TTM Dividend Yield 0.17%
3Y Average Dividend Yield 0.15%
Payout Ratio 2.63%
Expected Next Dividend Payment May 2026
Ex Date Announcement Date Payment Date Details
09 Jan 2026 24 Nov 2025 13 Feb 2026 0.035 Cash
24 Oct 2025 24 Sep 2025 14 Nov 2025 0.035 Cash
25 Jul 2025 01 Jul 2025 15 Aug 2025 0.035 Cash
25 Apr 2025 27 Mar 2025 15 May 2025 0.035 Cash
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 Cash
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 Cash
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 Cash
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 Cash
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 Cash
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 Cash
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 Cash
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2026 0.035 1 0.04
2025 0.140 4 0.17
2024 0.120 4 0.15
2023 0.090 3 0.12

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria